| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2021 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TR | 11 | Q2 2024 | 48.3% |
| SPDR INDEX SHS FDS | 11 | Q2 2024 | 18.3% |
| VANGUARD INDEX FDS | 8 | Q3 2023 | 26.4% |
| ISHARES TR | 8 | Q2 2024 | 23.3% |
| ISHARES TR | 6 | Q1 2023 | 6.0% |
| ISHARES TR | 5 | Q2 2024 | 27.4% |
| ISHARES TR | 5 | Q2 2024 | 21.4% |
| ISHARES TR | 5 | Q1 2023 | 4.3% |
| ISHARES TR | 4 | Q2 2024 | 12.1% |
| ISHARES TR | 4 | Q3 2022 | 5.6% |
View Hackensack Meridian Health, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-08-15 |
| N-PX | 2024-08-15 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-08 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-15 |
View Hackensack Meridian Health, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.